Brandel et al., 2016 - Google Patents
Structural aspects of solid solutions of enantiomersBrandel et al., 2016
- Document ID
- 6489689729555081721
- Author
- Brandel C
- Petit S
- Cartigny Y
- Coquerel G
- Publication year
- Publication venue
- Current Pharmaceutical Design
External Links
Snippet
A mixture of two enantiomers can crystallize according to three types of heterogeneous equilibria: a racemic compound (a 1: 1 stoichiometric compound), a conglomerate (a physical mixture of particles with opposite chirality) or, more rarely, as a solid solution (a …
- 239000006104 solid solution 0 title abstract description 79
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brandel et al. | Structural aspects of solid solutions of enantiomers | |
Berry et al. | Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients | |
Sheikh et al. | Scalable solution cocrystallization: case of carbamazepine-nicotinamide I | |
Brandel et al. | Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers | |
TWI379681B (en) | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | |
Kato et al. | Kinetic study of the transformation of mefenamic acid polymorphs in various solvents and under high humidity conditions | |
Grzesiak et al. | New form discovery for the analgesics flurbiprofen and sulindac facilitated by polymer‐induced heteronucleation | |
Wang et al. | Crystallization‐based separation of enantiomers | |
Zeidan et al. | Polymorphism of dehydro-aripiprazole, the active metabolite of the antipsychotic drug aripiprazole (abilify) | |
Oketani et al. | Deracemization in a Complex Quaternary System with a Second‐Order Asymmetric Transformation by Using Phase Diagram Studies | |
Harfouche et al. | Enabling direct preferential crystallization in a stable racemic compound system | |
de Diego et al. | Formation of solid solutions between racemic and enantiomeric citalopram oxalate | |
P Otto et al. | Solid state concerns during drug discovery and development: thermodynamic and kinetic aspects of crystal polymorphism and the special cases of concomitant polymorphs, co-crystals and glasses | |
JP7303821B2 (en) | Polymorphs and Solid Forms of Pyrimidinylamino-Pyrazole Compounds and Methods of Making | |
Davey et al. | The isolation of a metastable conglomerate using a combined computational and controlled crystallization approach | |
Le Minh et al. | Enantiomeric 3‐chloromandelic acid system: Binary melting point phase diagram, ternary solubility phase diagrams and polymorphism | |
Lerdwiriyanupap et al. | Combining diastereomeric resolution and Viedma ripening by using a racemic resolving agent | |
Li et al. | Solid tryptophan as a pseudoracemate: physicochemical and crystallographic characterization | |
Lee et al. | Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer? | |
Iwata et al. | Cocrystallization enhanced TAK-441 aqueous solubility and suppressed high solvatomorphism | |
Choobdari et al. | Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation | |
Nordstrom et al. | Concomitant Precipitation of Solid-State Miscible Product-Impurity Phases in Solution Crystallization–Part 2: Industrial Case Studies | |
KR20220143897A (en) | Optically resolved Trolox intermediate and method for preparing the same | |
EP3927692A1 (en) | Solidification or crystallisation method | |
Heffernan | An investigation into the effect of impurities on the crystallization of curcumin |